Skip to main content

Published locations for FDA panel backs riociguat for two types of pulmonary hypertension patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA panel backs riociguat for two types of pulmonary hypertension patients

User login

  • Reset your password
  • /content/fda-panel-backs-riociguat-two-types-pulmonary-hypertension-patients
  • /ehospitalistnews/article/77007/pulmonology/fda-panel-backs-riociguat-two-types-pulmonary
  • /rheumatologynews/article/77007/pulmonology/fda-panel-backs-riociguat-two-types-pulmonary
  • /ecardiologynews/article/77007/pulmonology/fda-panel-backs-riociguat-two-types-pulmonary-hypertension
  • /cardiology/article/77007/pulmonology/fda-panel-backs-riociguat-two-types-pulmonary-hypertension
  • /rheumatology/article/77007/pulmonology/fda-panel-backs-riociguat-two-types-pulmonary-hypertension